(AOF) – Walgreens Boots Alliance is among the bad pupils of a Dow Jones at half mast this Thursday: the title of the pharmacy brand indeed loses 1.2% to 53.34 dollars per share, despite the publication of results quarterly better than expected. The group has indeed reported a net profit of $ 3.58 billion in the first quarter of its fiscal year 2021-2022, or $ 4.13 per share, against a loss of $ 308 million a year ago. year. On an adjusted basis, Walgreens made a profit of $ 1.68 per share, while the FactSet consensus was targeting $ 1.36.
Sales increased 7.8% to 33.9 billion, against a consensus of 32.88 billion, largely thanks to tests and vaccines against covid: in the United States for example, sales in pharmacies increased by 1.1% (6.8% on a comparable basis), with a 6.2% increase in prescriptions filled, which includes a positive impact of approximately 535 basis points from vaccinations against covid-19. Sales of tests against the virus rose 16.6%.
The company said it administered 15.6 million vaccines and 6.5 million tests during its first quarter ended November 30, 2021.
In addition, Walgreens has also revised upwards its annual outlook and now expects growth of 1% to 5% (“low-single digit”), against previously stagnation.
© AOF
Legal disclaimer
The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights owned by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of hypertext link or reuse in any way whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to its gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of errors and defects, even hidden, nor the exhaustiveness or lack of conformity for any use whatsoever of these data and of OPTION FINANCE. SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.
Receive our latest news
Every morning, the information to remember about financial markets.